Ioflupane I-123 Completed Phase 3 Trials for Amyotrophic Lateral Sclerosis (ALS) Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic3
clinicaltrials.gov IdentifierTitleDrugs
NCT01160263Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls